Specialty Pharmacy Collaboration Summit

Transcription

1 September 15-17, 2014 Omni Parker House Boston, MA IIR s Partner to expand distribution, increase patient adherence and improve your bottom line HEAR EXPERTS FORECAST GROWTH & TRENDS AS THE AFFORDABLE CARE ACT REDEFINES THE INDUSTRY Ray Tancredi, RPh, MBA, CSP VP, Development Walgreens Co. Gregory W. Daniel, Managing Director, and Fellow, Engelberg Center for Health Care Reform, Brookings Institution Robert Popovian Senior Director, US Government Relations Pfizer Pharmaceuticals Reed Melton Executive Director, Center for Clinical Practices Blue Cross and Blue Shield Association NEVER-BEFORE-HEARD CASE STUDIES Accountable Care Impact on Payer Provider Relations from Aetna, BCBS, Tufts Health Plan, Denver Health Medical Plan and more! URAC AND CPPA ACCREDITATION WORKSHOP Improve operations and enhance compliance with URAC & CPPA Accreditations. INTRODUCING Facilitate more face-to-face meetings in 3 days across the specialty pharmacy ecosystem than in your entire year!

2 Pre-Conference Workshop Monday, September 15, 2014 URAC and CPPA Accreditation Workshop URAC Accreditation 9:00 Workshop Starts 10:00 Morning Networking Break URAC s Accreditation provides an external validation of excellence in Management and provides Continuous Quality Improvement (CQI) oriented processes that improve operations and enhance compliance. It also helps to assist in preparing for regulatory compliance. Key Takeaways: Learn how accreditation creates a pathway by which a pharmacy can build specialty pharmacy capabilities Develop a patient-centered specialty drug management approach Learn how to improve processes and procedures, promoting operational efficiencies while ensuring the highest level of customer service for a specialty pharmacy Understand how to build your specialty pharmacy business on quality benchmarks and performance outcome measures Janice Anderson, Director Pharmacy Programs, URAC 10:30 Workshop continues 12:00 Workshop continues Networking Lunch Center For Pharmacy Practice Accreditation 1:00 Meet the New Accreditor: Center for Pharmacy Practice Accreditation (CPPA ) The Center for Pharmacy Practice Accreditation (CPPA ) is a partnership established by the American Pharmacists Association (APhA), the National Association of Boards of Pharmacy (NABP), and the American Society of Health-System Pharmacists (ASHP) to provide accreditation for pharmacy practice sites. CPPA accredits those pharmacy practices that deliver high quality, safe and efficient patient care services. Presentation Highlights: What makes CPPA unique in the specialty pharmacy accreditation market The four primary areas of specialty pharmacy practice (standard domains) which encompass the overall provision of care. The presentation will review the o Standards development process o The accreditation standards o The metrics and reports required for accreditation Lynnae M Mahaney, BSPharm, MBA, FASHP, Executive Director, CPPA Terri Smith Moore, PhD, MBA, R.Ph, Consultant, MOORE ASSOCIATES 2:00 The Accreditation Experience: Duke University Medical Center Duke University Medical Center became the first beta site to vet the CPPA Pharmacy Practice accreditation process. Learn about their experience. Paul Bush, PharmD, MBA, FASHP, BCPS, Chief Pharmacy Officer, Duke University Hospital 3:15 Community/ Practice Accreditations for Distribution Channel Partners Gary Rice, Vice President, Clinical Services, Diplomat Accreditation brings value along the medication management continuum of care involving multiple pharmacy practice providers. Accreditation is a valuable asset in Diplomat s unique delivery model of specialty pharmacy care. 4:00 Practice Accreditation and the Payer Learn how CPPA accreditation is a differentiating factor for preferred pharmacy networks and aligns with the quality initiatives in the healthcare marketplace and payer goals. Anthony Staresinic, Director of Pharmacy, Unity Health Point 4:45 Wrap-Up Main Conference Day One Tuesday, September 16, :15 Registration Opens & Morning Coffee 8:45 Chairperson s Welcome & Opening Remarks : Evolving to Meet Patient Needs and Healthcare Challenges Ray Tancredi, RPh, MBA, CSP, VP, Specialty Pharmacy Development, Walgreens Co. 9:30 The True Value of : A Direct Impact on Bottom Line Revenue and Profits This session will give you a 360 perspective on the impact of specialty pharmacies on bottom line profits and costs. As the industry comes under scrutiny for unprecedented profit margins and transferring cost burdens onto patients; hear from leaders in the space as they discuss the implications of strategies used internally and the implicit bottom line benefits. Reed Melton, Executive Director, Center for Clinical Practices, Blue Cross and Blue Shield Association Bhavesh Shah RPh, BCOP, Hematology/Oncolgoy Pharmacy Manager, Boston Medical Center 10:15 Management in Commercial Health Plans PAYER PANEL This payer panel discussion will shed light on commercial plan strategies and priorities as collaboration with specialty pharmacies and pharma becomes integral to their success. What are payers top specialty pharmacy priorities and management goals? How does payer management intensity vary by therapeutic category? How does payer focus on cost management versus clinical management vary by specialty category? Michelle Beozzo, PharmD, Director of Pharmacy Services, Managed Care, Denver Health Medical Plan

3 Main Conference Day One Tuesday, September 16, 2014 David Brumley, MD, MBA, Senior Medical Director, Tufts Health Plan Pavel Lavitas, PharmD, BCPS, Clinical Consultant Pharmacist, UMass Medical School, Clinical Pharmacy Services 11:00 Networking Break 11:15 What Is the Value of High Cost Specialty Medicines? KEY NOTE Health care payment systems are evolving, where there is a greater emphasis on global payments tied to quality performance. In this session, Robert will discuss the optimal methodologies to assess the value and cost proposition of specialty medicines in the evolving payment policy environment by discussing the importance of: Defining quality measures for specialty medicines Ensuring global payment models which encapsulate all costs and outcomes including those for pharmaceuticals Developing measures of quality and value that are relevant to patients Robert Popovian, Senior Director, US Government Relations, Pfizer Pharmaceuticals 12:00 Networking Lunch 1:00 Optimize the Patient Experience Specialty pharmacy has advanced over the years to better meet patients needs receiving specialty medications as advancements in medication treatment are continually evolving and improving. The high-touch patient care approach goes beyond advanced care clinical models and now also includes the in-take process and gaining patient access via prior approval, appeals, and patient financial support to gain access to the medication. Key take-a-ways from the presentation includes: The patient journey from a new prescription, a refill, and medication compliance program examples. Explain the infrastructure, administrative requirements, and effective practices for managing high-touch patient care. Identify possible methods for data collecting of health outcomes in a specialty pharmacy. Gary Rice, RPh, MS, MBA, CSP, Vice President, Clinical Services, Diplomat 1:45 From Raw Data to Big Data: The Value of Data Management As the growing specialty pharmacy niche is becoming a major force in the health care industry, the need to effectively manage ever more complex data has become a challenge. This session will run you through the importance of aggregating data and measuring outcomes for all stakeholders patients, pharmacies, prescribers, manufacturers and insurers. The feasibility of transparency & stakeholder collaboration How to manage complex data & turn it into driven decisions Donna Trane,VP Business Development, Accredo Health Group 2:30 Networking Break 2:45 Under the Microscope ROUND TABLE Managing the cost of these extremely expensive and essential specialty drugs is key to patients. This roundtable gives you the opportunity to hone in on the specifics of each of these life threatening diseases. Hear our roundtable leaders as they shed light on their expertise with each of these disease states: Roundtable 1: Multiple Sclerosis Roundtable 2: Cancer Chris Fausel, Head of Pharmacy for Oncology, Iu health cancer center Roundtable 3: Hepatitis C Stephanie Padoan RN, BSN, MS, Director of Clinical Strategy and Development, Aetna 3:45 Impact of ACOs and Issues of Fragmentation of Care This session will discuss: ACOs and their impact on specialty pharmacy The role of academic medical centers on the effective management of population risk and healthcare cost Current issues with fragmentation of care The role of integrated practice units Kevin J. Colgan, R.Ph., MA, Director of Pharmacy, Rush University Medical Center 4:30 Close of Conference Day One Main Conference Day Two Wednesday, September 17, :00 Registration Opens & Morning Coffee 9:15 Chairperson s Recap of Day One 9:45 Embracing the Affordable Care Act for Specialty Pharmacy Gregory W. Daniel, Managing Director and Fellow, Engelberg Center for Health Care Reform, THE Brookings Institution 10:15 Changing the Channel: A Pharmaceutical Distribution Perspective Today, specialty pharmaceuticals are special indeed: they are dominating pipelines, and their sales are forecasted to grow at twice the rate of traditional products for the next five years, but with such rapid growth comes equally rapid change. What strategies can help companies sustain their commercial success? Develop sound distribution strategies How to position within the channel to gain a competitive advantage Richard Peters, MD, PhD, Strategy Development Officer, Genzyme Sylvia Bartel, VP Pharmacy, DANA-FARBER CANCER INSTITUTE, HARVARD UNIVERSITY 11:00 Networking Break REGISTER TODAY! Call: register@iirusa.com

4 Main Conference Day Two Wednesday, September 17, :15 Has The Generic Wave and Specialty Boom Restructured the U.S. Pharmacy Industry Forever? EXCL- USIVE This session will open you up to a full fledged debate from industry leaders who understand the benefits of both the generics wave and the specialty boom. This never-beforeheard session discusses the strategic and tactical steps decision makers need to hop on to the bandwagon and reap the bottom line benefits. 12:00 Networking Lunch 1:00 The Space Niche No More? ROUND TABLE In addition to the many pharmacies that already have specialty capabilities, new sources of competition are rapidly emerging. This roundtable allows you to pick your poison and join the discussion most relevant to you! Roundtable 1: Independent Retail Community Pharmacies Nick Calla, VP Industry Relations, Community Network Roundtable 2: Regional and National Chains Launching Specialty at Retail Programs Christopher Benz, Business Development Director, Armada Health CARE Brian Burke, Vice President, National Accounts, Armada Health Care Roundtable 3: Private, Independent Specialty Pharmacies Rebecca M. Shanahan, Esq. Chief Executive Officer, Avella 2:00 How Will Evolve in A Risk- Sharing Environment? This session will touch on Specialty Therapy Management Adherence Cost Management Mike Reilly, President, Pharmacy Benefit Dimensions, INDEPENDENT HEALTH 2:45 Is the SP Advantage Sustainable? PANEL There is no one single answer to how to best manage this category of drugs, and the impact of these agents on the overall medical cost curve is still somewhat unknown. For instance, will some chronic diseases ultimately cost the system less due to the potential for specialty drugs to modify the course of a chronic disease? Or, will these potential cost savings be outweighed by a growing number of patients living longer with chronic conditions. This closing panel will discuss the: Challenges of effectively managing this benefit and the costs associated with it. What will be the impact of biosimilars? What does the future hold? Panelists: Mike Reilly, President, Pharmacy Benefit Dimensions, INDEPENDENT HEALTH 3:30 Chairperson s Closing Remarks & Close of Conference Pricing & hotel 3 Easy Ways to Register Easiest! Call: US register@iirusa.com For complete registration, discount, payment and cancellation policies, visit: Save $600 Save $400 Save $200 Pharma, Biotech, Specialty Pharmacies, Solution Providers Main Conference + Pre-Conference Workshop By 6/27/14 By 7/25/14 By 8/22/14 Standard Rate $2,595 $2,795 $2,995 $3,195 Main Conference $1,795 $1,995 $2,195 $2,395 Save $400 Save $200 Health Plans By 7/25/14 By 8/22/14 Standard Rate Main Conference + Pre-Conference Workshop $1,595 $1,795 $1,995 Main Conference $795 $995 $1,195 Team & Group Discounts IIR s is designed for teams! There is too much information available for just one person to capture it all. Plus, attendees of a conference walk away with the most value when they experience it with a peer. SAVE 10% SAVE 15% GROUPS of 9+ Off the current rates for teams of 3-5 Off the current rates for teams of 6-8 Please contact Millison Thenor at mthenor@iirusa.com or to customize a registration package! HOTEL Omni Parker House 60 School Street Boston, MA (617) Room Rate is $299/night + tax. Call THE-OMNI; deadline is August 15, 2014 or until sold out Institute for International Research, Inc. All rights reserved

5 IIR s Dear Colleague, Increasing health care costs backed by the reforms and changes brought about by Health Care Reforms and the ACA are a continuing challenge for all stakeholders within the health care landscape. Payers efforts to reduce costs and keep their premiums competitive in order to maintain profitability also put pressure on providers and patients. Providers are facing declining reimbursement and rising costs as they work to keep their doors open, while patients are facing increased cost shares for drugs and services particularly for high-cost specialty products. Adding to the stakeholder challenges is the continued development of highly complex, high-cost specialty therapies and the distribution of these drugs. IIR s is the only event in the industry bringing together all critical stakeholders in the specialty pharmacy value chain, including the leading pharmaceutical companies, health plans, and specialty pharmacies as the landscape develops year on year. By 2013, global revenue from specialty products will exceed $160 billion. IMS Health Join us in September as we convene to provide you with a roadmap for managing the future impact of specialty pharmacies. I look forward to seeing you there! Kind Regards, Sakina Hussain Conference Director IIR s NEW! INTRODUCING Engage in pre-event discussions, view who is attending and arrange one-toone meetings with partnering360. Foster meaningful engagement and build relationships with key stakeholders in the specialty pharmacy value chain to achieve your personal objectives and your company s collaborative aims. WHO SHOULD ATTEND Pharma,, and Biotech: Managed Markets Market Access Managed Care National Accounts Regional Accounts Health Plans: Medical Director VP / Director / Managers of Pharmacy & PBM s VP / Director / Managers of Specialty Pharmacy VP / Directors of Pharmacy Services Pharmacy Benefit Manager Build Relationships with Decision Makers To learn how to sponsor or exhibit, please contact Patricia Rose at or prose@iirusa.com. Media Partners (as of ) IIR s is designed to facilitate P.S. networking, collaboration and integration between all key stakeholders in the evolving value chain. Register your whole team and save up to 15% off the current registration rates! Contact Millison Thenor today at to develop a customized registration package for your team! REGISTER TODAY! Call: register@iirusa.com

6 IIR s September 15-17, 2014 Omni Parker House Boston, MA All new! Institute for International Research 708 Third Ave New York, NY Route to Manager / Director: Regional / National Accounts Managed Markets Pharmacy Introducing Powered by partnering360, this collaborative summit is designed to facilitate networking and integration between all key stakeholders in the evolving specialty pharmacy value chain. Efficiently meet with the right people and navigate the increasingly complex, yet essential relationship between payers, pharma manufacturers and specialty pharmacies. With partnering360, you can: Engage in pre and post event discussions view who is attending the event arrange one-to-one meetings P1968 September 15-17, 2014 Omni Parker House Boston, MA IIR s SAVE UP TO $400 off the Standard Registration Rates by 7/25 Partner to expand distribution, increase patient adherence and improve your bottom line Why Attend? Collaborate with manufacturers, insurance plans and specialty pharmacies to develop consistency and clarity around the integration of all stakeholders in the value chain. Payer/ Health Plans Partner for additional options to better manage your costs, patient adherence and utilization while maintaining your bottom line. Pharma Manufacturers Gain insights into the growing industry, and get access to controlled or closed distribution channels for specialty drugs. Specialty Pharmacies Showcase how your infrastructure can provide immediate insight into patient compliance, sideeffect tracking, and targeted management of specialty drugs while controlling health care costs.